PPT-Committed to Becoming a Leader in Topical Drug Development
Author : mitsue-stanley | Published Date : 2018-01-31
Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown PA 18902 USA Tel 732 2303838 Fax 732 2303840 wwwiviewtherapeuticscom Bo Liang PhD MBA CoFounder
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Committed to Becoming a Leader in Topica..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Committed to Becoming a Leader in Topical Drug Development: Transcript
Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown PA 18902 USA Tel 732 2303838 Fax 732 2303840 wwwiviewtherapeuticscom Bo Liang PhD MBA CoFounder amp Director. Sabre. 6. The Regiment of Mounted Riflemen!. 1. Agenda. Introduction. Purpose. References. Lesson #1. What is leadership?. Why do we develop leaders?. How do we develop leaders?. Break. My philosophy on Leader Development. Recognizing the Lessons and Stages of Leadership Development. Leaders who make decisions for others need to understand the various factors that . allow convergence. : role-match, giftedness, experience, spiritual maturity, destiny, geographic location. When you can’t agree to disagree. Consensus. Why do applications need consensus?. What does it mean to have consensus?. Consensus = consistency. Assumptions. Processes can choose values. Run at arbitrary speeds. Mental picture of . what’s happening . inside…. … really might help.. Drug action (effects). Proportional to concentration at site of action. Concentration predicts better than dose. General Rules. Sabre. 6. The Regiment of Mounted Riflemen!. 1. Agenda. Introduction. Purpose. References. Lesson #1. What is leadership?. Why do we develop leaders?. How do we develop leaders?. Break. My philosophy on Leader Development. M ı celles as nanos ı zed carr ı ers for sk ı n del ı very of drugs S evgi Güngör Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology 4 th International Conference on DRUGS FOR CUTANEOUS MYCOTIC INFECTIONS. Squalene. . Epoxidase. Inhibitors. These . agents act by inhibiting . squalene. . epoxidase. , thereby . blocking the biosynthesis of . ergosterol. , an essential component of the fungal cell membrane.. . Ajai. . Agrawal. Additional Professor. Department of Ophthalmology. A.I.I.M.S., . Rishikesh. Learning Objectives. At the end of this class students shall . have a basic understanding of :. pharmacokinetics and . Adam Fityan. Consultant Dermatologist University Hospital Southampton. and. Honorary Consultant Dermatologist, St John’s Institute of Dermatology, London. Eczema. O. nset. , pattern and . severity. Extra notes were added to the slides and a sheet was not submitted due to the fact that doctor only mentioned minor details and mostly read from the slides without adding any notable information . Two parentheses () will indicate any extra information added to the slides . M.PHARM. PHARMACEUTICS-I SEM. Introduction. The external eye is readily accessible for drug administration. As a consequence of its function as the visual apparatus, mechanisms are strongly developed for the clearance of foreign materials from the cornea to preserve visual acuity. This presents problems in the development of formulations for ophthalmic therapy. Dr. . Sura. Al . Zoubi. MMS . Pharmacology. . Lecture 5. 1. TOPICAL CORTICOSTEROIDS. Corticosteroids (glucocorticoids) have immunosuppressive and . antiinflammatory. properties. . . Topical . corticosteroids are used for the . for Replicated Logs. Diego Ongaro and John Ousterhout. Stanford University. Replicated log => . replicated state . machine. All servers execute same commands in same . order. Consensus module ensures proper log replication. experience. and . its. . relevance. . to. North . African. . countries. Ivo Morawski. OUTLINE OF THE PRESENTATION. The LEADER . experience. LEADER . highlights. Description. . of. a LEADER case .
Download Document
Here is the link to download the presentation.
"Committed to Becoming a Leader in Topical Drug Development"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents